Marketing-authorisation holder
Wyeth Ayerst
66 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
66 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 66
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANSOLYSEN10mg/ml · Injectable | Pentolinium | United States | Not marketed | |
| ATROMID-S500mg · Capsule | Clofibrate | United States | Not marketed | 1967 |
| BICILLIN200,000 units · Tablet | Benzathine benzylpenicillin | United States | Not marketed | |
| BICILLIN300,000 units/5ml · Suspension | Benzathine benzylpenicillin | United States | Not marketed | 1951 |
| CEFPIRAMIDE SODIUM10gm base/vial | 1gm base/vial | 2gm base/vial · Injectable | Cefpiramide | United States | Not marketed | 1989 |
| CERUBIDINE20MG BASE/VIAL | 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Daunorubicin | United States | Marketed | 1979 |
| CYCLAPEN-W125mg/5ml | 250mg/5ml | 500mg/5ml · For suspension | Cyclacillin | United States | Not marketed | 1979 |
| CYCLAPEN-W250mg | 500mg · Tablet | Cyclacillin | United States | Not marketed | 1979 |
| DIMENHYDRINATE50mg/ml · Injectable | Dimenhydrinate | United States | Marketed | 1974 |
| DIMETANE-TEN10mg/ml · Injectable | Brompheniramine | United States | Not marketed | 1958 |
| DIUCARDIN50mg · Tablet | Hydroflumethiazide | United States | Not marketed | 1973 |
| EQUANIL400mg · Capsule | Meprobamate | United States | Not marketed | |
| EQUANIL200mg | 400mg · Tablet | Meprobamate | United States | Not marketed | 1955 |
| ESTRADURIN40mg/amp · Injectable | Polyestradiol | United States | Not marketed | 1957 |
| ESTROGENIC SUBSTANCE2mg/ml · Injectable | Estrone | United States | Not marketed | |
| FLUOTHANE99.99% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Liquid | Halothane | United States | Not marketed | 1958 |
| GRISACTIN125mg | 250mg · Capsule | Griseofulvin, Microcrystalline | United States | Not marketed | 1962 |
| GRISACTIN500mg · Tablet | Griseofulvin, Microcrystalline | United States | Not marketed | 1972 |
| GRISACTIN ULTRA125mg | 165mg | 250mg | 330mg · Tablet | Griseofulvin, Ultramicrocrystalline | United States | Not marketed | 1980 |
| INDERAL10mg/ml · Suspension | Propranolol | United States | Not marketed | 1986 |
| INDERIDE LA 120/5050mg; 120mg · Capsule, extended release | Hydrochlorothiazide, Propranolol | United States | Not marketed | 1985 |
| INDERIDE LA 160/5050mg; 160mg · Capsule, extended release | Hydrochlorothiazide, Propranolol | United States | Not marketed | 1985 |
| INDERIDE LA 80/5050mg; 80mg · Capsule, extended release | Hydrochlorothiazide, Propranolol | United States | Not marketed | 1985 |
| ISORDIL40mg · Capsule, extended release | Isosorbide dinitrate | United States | Not marketed | |
| ISORDIL40mg · Tablet, extended release | Isosorbide dinitrate | United States | Not marketed |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 66 | 66 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Wyeth Ayerst’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.